Biocon has acquired 2 companies, including 1 in the last 5 years.
Biocon’s largest acquisition to date was in 2022, when it acquired Viatris - Biosimilars for $3.3B. Biocon has acquired in 2 different US states. The Company’s most targeted sectors include life science (50%) and medical products (50%).
20th KM, Hosur Road Electronics City,
Bengaluru,
560100
India,
+91 80 2808 2808
www.biocon.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2022-02-28 |
Viatris - Biosimilars · Life Science
Canonsburg, Pennsylvania Viatris' Biosimilars provides affordable access to patients through its portfolio in diabetes, oncology, immunology, and other non-communicable diseases. Viatris' Biosimilars is based in Canonsburg, Pennsylvania. |
3,335 | Divestiture |
Biocon
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
